Skip to main content

Advertisement

Log in

Are inhaled corticosteroids associated with an increased risk of fracture in children?

  • Original Article
  • Published:
Osteoporosis International Aims and scope Submit manuscript

Abstract

Inhaled corticosteroids are widely used in the long-term management of asthma in children. Data on the relationship between inhaled corticosteroid therapy and osteoporotic fracture are inconsistent. We address this issue in a large population-based cohort of children aged 4–17 years in the UK (the General Practice Research Database). The incidence rates of fracture among children aged 4–17 years taking inhaled corticosteroids (n=97,387), taking bronchodilators only (n=70 984) and a reference group (n=345,758) were estimated. Each child with a non-vertebral fracture (n=23,984) was subsequently matched by age, sex, practice, and calendar time to one child without a fracture. Fracture incidence was increased in children using inhaled corticosteroids, as well as in those receiving bronchodilators alone. With an average daily beclomethasone dose of 200 μg or less, the crude fracture risk relative to nonusers was 1.10 [95% confidence interval (CI), 0.96–1.26]; with dosage of 201–400 μg, it was 1.23 (95% CI, 1.08–1.39); and with dosages over 400 μg, it was 1.36 (95% CI, 1.11–1.67). This excess risk disappeared after adjustment for indicators of asthma severity. The increased risk of fracture associated with use of inhaled corticosteroids is likely to be the result of the underlying illness, rather than being directly attributable to inhaled corticosteroid therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. British Thoracic Society (1997) The British guidelines on asthma management: 1997 review and position statement. Thorax 52:S1–S21

    Google Scholar 

  2. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993–1000

    PubMed  Google Scholar 

  3. Kinberg KA, Hopp RJ, Biven RE, Gallagher JC (1994) Bone mineral density in normal and asthmatic children. J Allergy Clin Immunol 94:490–497

    CAS  PubMed  Google Scholar 

  4. Hopp RJ, Degan JA, Biven RE, Kinberg K, Gallagher GC (1995) Longitudinal assessment of bone mineral density in children with chronic asthma. Ann Allergy 75:143–148

    CAS  Google Scholar 

  5. Konig P, Hillman L, Cervantes C, Levine C, Maloney C, Douglass B, Johnson L, Allen S (1993) Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 122:219–226

    PubMed  Google Scholar 

  6. Agertoft L, Pedersen S (1998) Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 157:178–183

    CAS  PubMed  Google Scholar 

  7. Martinati LC, Bertoldo F, Gasperi E, Micelli S, Boner AL (1996) Effect on cortical and trabecular bone mass of different anti-inflammatory treatments in preadolescent children with chronic asthma. Am J Respir Crit Care Med 153:232–236

    CAS  PubMed  Google Scholar 

  8. Gregson RK, Rao R, Murrills AJ, Taylor PA, Warner JO (1998) Effect of inhaled corticosteroids on bone mineral density in childhood asthma: comparison of fluticasone propionate with beclomethasone dipropionate. Osteoporos Int 8:418–422

    Article  CAS  PubMed  Google Scholar 

  9. Baraldi E, Bollini MC, De Marchi A, Zacchello F (1994) Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 7:710–714

    Article  CAS  PubMed  Google Scholar 

  10. Martinati LC, Bertoldo F, Gasperi E, Fortunati P, Lo Cascio V, Boner AL (1998) Longitudinal evaluation of bone mass in asthmatic children treated with inhaled beclomethasone dipropionate or cromolyn sodium. Allergy 53:705–708

    CAS  PubMed  Google Scholar 

  11. The Childhood Asthma Management Program Research Group (2000) Long-term effects of budesonide or nedocromil in children with asthma. N Engl J Med 343:1054–1063

    Article  PubMed  Google Scholar 

  12. Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB (2000) Effects of high-dose inhaled corticosteroids on bone metabolism in prepubertal children with asthma. Pediatr Pulmonol 29:188–193

    Article  CAS  PubMed  Google Scholar 

  13. Chay OM, Goh A, Lim WH, Leong KH, Lou J (1999) Effects of inhaled corticosteroid on bone turnover in children with bronchial asthma. Respirology 4:63–67

    Article  CAS  PubMed  Google Scholar 

  14. Konig P, Hillman L, Cervantes C, Levine C, Maloney C, Douglass B, Johnson L, Allen S (1993) Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Pediatr 122:219–226

    PubMed  Google Scholar 

  15. Birkebaek NH, Esberg G, Andersen K, Wolthers O, Hassager C (1995) Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 73:524–547

    CAS  PubMed  Google Scholar 

  16. Sorva R, Turpeinen M, Juntunen-Backman K, Karonen SL, Sorva A (1992) Effects of inhaled budesonide on serum markers of bone metabolism in children with asthma. J Allergy Clin Immunol 90:808–815

    CAS  PubMed  Google Scholar 

  17. Price J (2000) The role of inhaled corticosteroids in children with asthma. Arch Dis Child 82:ii10–ii14

    Article  PubMed  Google Scholar 

  18. McNicol KN, Williams HE, Gillam G (1970) Chest deformity, residual airways obstruction and hyperinflation, and growth in children with asthma. I. Prevalence findings from an epidemiological study. Arch Dis Child 45:783–788

    CAS  PubMed  Google Scholar 

  19. Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350:1097–1099

    Article  CAS  PubMed  Google Scholar 

  20. van Staa TP, Abenhaim L (1994) The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 3:15–21

    Google Scholar 

  21. van Staa TP, Abenhaim L, Cooper C (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359–366

    Article  Google Scholar 

  22. British Medical Association and the Royal Pharmaceutical Society of Great Britain (1998) British National Formulary Number 36 (September). Pharmaceutical Press, Wallingford, UK

  23. Breslow NE, Day NE (1987) Statistical methods in cancer research. International Agency for Research on Cancer, Lyon

  24. Chinn S, Rona RJ (2001) Can the increase in body mass index explain the rising trend in asthma in children? Thorax 56:845–850

    Article  CAS  PubMed  Google Scholar 

  25. Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW, Lewis-Barned NJ (1998) Bone mineral density in girls with forearm fractures. J Bone Miner Res 13:143–148

    Google Scholar 

  26. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM (2000) More broken bones: a 4-year double cohort study of young girls with and without distal forearm fractures. J Bone Miner Res 15:2011–2018

    CAS  PubMed  Google Scholar 

  27. Goulding A, Jones IE, Taylor RW, Manning PJ, Williams SM (2001) Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy X-ray absorptiometry study. J Pediatr 139:509–515

    Article  CAS  PubMed  Google Scholar 

  28. Pettersson U, Nordstrom P, Alfredson H, Henriksson-Larsen K, Lorentzon R (2000) Effect of high impact activity on bone mass and size in adolescent females: a comparative study between two different types of sports. Calcif Tissue Int 67:207–214

    Article  CAS  PubMed  Google Scholar 

  29. Nordstrom P, Pettersson U, Lorentzon R (1998) Type of physical activity, muscle strength, and pubertal stage as determinants of bone mineral density and bone area in adolescent boys. J Bone Miner Res 13:1141–1148

    Google Scholar 

  30. Krahl H, Michaelis U, Pieper HG, Quack G, Montag M (1994) Stimulation of bone growth through sports. A radiologic investigation of the upper extremities in professional tennis players. Am J Sports Med 22:751–757

    CAS  PubMed  Google Scholar 

  31. Clark CJ, Cochrane LM (1988) Assessment of work performance in asthma for determination of cardiorespiratory fitness and training capacity. Thorax 43:745–749

    CAS  PubMed  Google Scholar 

  32. Counil FP, Karila C, Varray A, Guillaumont S, Voisin M, Prefaut C (2001) Anaerobic fitness in children with asthma: adaptation to maximal intermittent short exercise. Pediatr Pulmonol 31:198–204

    Article  CAS  PubMed  Google Scholar 

  33. Clark CJ, Cochrane LM (1999) Physical activity and asthma. Curr Opin Pulmon Med 5:68–75

    Article  CAS  Google Scholar 

  34. Chen Y, Dales R, Krewski D (2001) Leisure-time energy expenditure in asthmatics and non-asthmatics. Respir Med 95:13–18

    Article  CAS  PubMed  Google Scholar 

  35. Price JF (2001) Choices of therapy for exercise-induced asthma in children. Allergy 56:12–17

    Article  Google Scholar 

  36. Simons FER (1997) Canadian Beclomethasone Dipropionate–Salmeterol Xinafoate Study Group. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. N Engl J Med 337:1659–1665

    Article  CAS  PubMed  Google Scholar 

  37. Agertoft L, Pedersen S (2000) Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 343:1064–1069

    Article  CAS  PubMed  Google Scholar 

  38. van Staa TP, Leufkens HGM, Cooper C (2001) Use of inhaled corticosteroids and risk of fractures. J Bone Miner Res 16:581–588

    PubMed  Google Scholar 

  39. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G (2003) Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease (Cochrane Review). The Cochrane Library, Issue 3. Update Software, Oxford

  40. Richy F, Bousquet J, Ehrlich GE, Meunier PJ, Israel E, Morii H, Devogelaer J-P, Peel N, Haim M, Bruyere O, Reginster J-Y. Inhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic review. Osteoporos Int 2003;14:179–190

    Google Scholar 

  41. Sin DD, Man JP, Man SF (2003) The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med 114:10–14

    Article  PubMed  Google Scholar 

  42. Lekamwasam S, Trivedi DP, Khaw KT (2002) An association between respiratory function and bone mineral density in women from the general community: a cross-sectional study. Osteoporos Int 13:710–715

    Article  Google Scholar 

  43. Pellegrino M, Minervini B, Musto P, Matera R, Greco A, Checchia de Ambrosio C (1996) Tumor necrosis factor-alpha and interleukin-1 beta. Two possible mediators of allergic inflammation. Minerva Pediatr 48:309–312

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Procter & Gamble Pharmaceuticals funded the study. We thank EPIC for their support in providing the GPRD data. N.J. Bishop and C. Cooper are supported by the Arthritis Research Campaign.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cyrus Cooper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Staa, TP., Bishop, N., Leufkens, H.G.M. et al. Are inhaled corticosteroids associated with an increased risk of fracture in children?. Osteoporos Int 15, 785–791 (2004). https://doi.org/10.1007/s00198-004-1606-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-004-1606-5

Keywords

Navigation